23 October 2026 ASX Announcement September 2026 Quarterly Activity Report Firebrick Pharma Limited (ASX:FRE) (Firebrick, Company) is pleased to provide its business activity update for the quarter ending 30 September 2026, along with its Appendix 4C quarterly cash flow report. REVIEW OF QUARTERLY...
September 2026 Quarterly Activity Report & Appendix 4C
Filed with ASX ·
6ix is reading this filing.
Firebrick Pharma Limited on 6ix
Story so far
Earlier from Firebrick Pharma
- New Product - Nasodine Sinus Rinse
- Nasodine Nasal Spray Approved in the Philippines
- Firebrick Secures $732k in Strategic Investments
- Firebrick announces USA Retail Launch Plan
- Firebrick receives $293,000 R&D Tax Incentive
Follow Firebrick Pharma into a list and get an email when it puts out news.
Follow Firebrick Pharma